Skip to main content

Advertisement

SpringerLink
Log in

In vitro activity of the new quinolone RO 23-6240 (AM-833) and the new cephalosporins RO 15-8074 and RO 19-5247 (T-2525) againstMycobacterium fortuitum andMycobacterium chelonae

  • Published:
European Journal of Clinical Microbiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Sommers, H. M., Good, R. C.:Mycobacterium. In: Lennette, E. H., Balows, A., Hausler, W. J., Shadomy, H. J. (ed.): Manual of clinical microbiology. American Society for Clinical Microbiology, Washington, DC, 1985, p. 216–248.

    Google Scholar 

  2. Vestal, A.: Procedures for the isolation and identification of mycobacteria. Centers for Disease Control, Atlanta, GA, 1975, p. 97–115.

    Google Scholar 

  3. Swenson, J., Wallace, R., Silcox, V. A., Thornsberry, C.: Antimicrobial susceptibility to five subgroups ofMycobacterium fortuitum andMycobacterium chelonae. Antimicrobial Agents and Chemotherapy 1985, 28: 807–811.

    PubMed  Google Scholar 

  4. Gay, J. D., DeYoung, D. R., Roberts, G. D.: In vitro activities of norfloxacin and ciprofloxaxin againstMycobacterium tuberculosis, M. avium complex,M. chelonei, M. fortuitum andM. kansasii. Antimicrobial Agents and Chemotherapy 1984, 26: 94–96.

    PubMed  Google Scholar 

  5. Swenson, J. M., Thornsberry, C., Silcox, V. A.: Rapidly growing mycobacteria: testing of susceptibility to 34 antimicrobial agents by broth microdilution. Antimicrobial Agents and Chemotherapy 1982, 22: 186–192.

    PubMed  Google Scholar 

  6. Finch, R.: Beta-lactam antibiotics and mycobacteria. Journal of Antimicrobial Chemotherapy 1986, 18: 6–8.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pharma Research Department, F. Hoffmann-La Roche & Co. Ltd., Basel, Switzerland

    P. Hohl

  2. Department of Medical Microbiology, University of Zurich, Zurich, Switzerland

    M. Salfinger & F. M. Kafader

Authors
  1. P. Hohl
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Salfinger
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. F. M. Kafader
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hohl, P., Salfinger, M. & Kafader, F.M. In vitro activity of the new quinolone RO 23-6240 (AM-833) and the new cephalosporins RO 15-8074 and RO 19-5247 (T-2525) againstMycobacterium fortuitum andMycobacterium chelonae . Eur. J, Clin. Microbiol. 6, 487–488 (1987). https://doi.org/10.1007/BF02013118

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02013118

Keywords

Search

Navigation